NCT02125981View on ClinicalTrials.gov

The Study About the Efficacy of Oral Limaprost After Surgery for Cervical Myelopathy

PHASE3CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

September 1, 2014

Primary Completion Date

October 1, 2022

Study Completion Date

April 1, 2023

Conditions
Cervical Myelopathy
Interventions
DRUG

Limaprost

taking Limaprost α-Cyclodextrin Clathrate 1 Tablets (166.67 μg), three times per day

DRUG

Placebo

taking placebo drug

Trial Locations (1)

463-707

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT02125981 - The Study About the Efficacy of Oral Limaprost After Surgery for Cervical Myelopathy | Biotech Hunter | Biotech Hunter